ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $91,059 | -27.5% | 30,353 | -9.6% | 0.00% | – |
Q2 2023 | $125,627 | -72.6% | 33,590 | -75.5% | 0.00% | -100.0% |
Q1 2023 | $459,221 | -36.7% | 137,081 | -9.2% | 0.00% | -50.0% |
Q4 2022 | $725,771 | +317.1% | 150,888 | +394.5% | 0.00% | – |
Q3 2022 | $174,000 | -77.4% | 30,512 | -71.8% | 0.00% | -100.0% |
Q2 2022 | $769,000 | -62.2% | 108,297 | -61.5% | 0.00% | -50.0% |
Q1 2022 | $2,032,000 | – | 281,475 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 1,265,631 | $27,186,000 | 91.01% |
Yu Fan | 143,867 | $3,090,000 | 34.92% |
AJU IB Investment Co., Ltd. | 1,745,331 | $37,490,000 | 21.62% |
Bain Capital Life Sciences Investors, LLC | 5,615,659 | $120,624,000 | 7.90% |
Cormorant Asset Management, LP | 6,411,355 | $137,716,000 | 4.68% |
Ally Bridge Group (NY) LLC | 373,288 | $8,018,000 | 1.99% |
RA Capital Management | 5,368,451 | $115,314,000 | 1.85% |
Omega Fund Management, LLC | 746,868 | $16,043,000 | 1.82% |
CM Management, LLC | 90,000 | $1,933,000 | 1.40% |
SECTORAL ASSET MANAGEMENT INC | 538,884 | $11,575,000 | 0.94% |